Traditional Herbal Drugs against Liver Diseases – Experimented in vitro using HepG2 Cells for Induced Steatosis

IF 0.6 Q4 PHARMACOLOGY & PHARMACY
Ayse Esra KARADAG, M. E. Okur, Y. Özhan, Hande Si̇pahi̇, Fatih Demirci
{"title":"Traditional Herbal Drugs against Liver Diseases – Experimented in vitro using HepG2 Cells for Induced Steatosis","authors":"Ayse Esra KARADAG, M. E. Okur, Y. Özhan, Hande Si̇pahi̇, Fatih Demirci","doi":"10.29228/jrp.467","DOIUrl":null,"url":null,"abstract":": Salvia fruticosa leaves, Malva sylvestris flowers, Taraxacum officinale aerial parts, Plantago ovata seeds, Tanacetum parthenium aerial parts, and Allium sativum bulbs are documented for traditional use against hepatic disorders and different liver diseases. To evaluate herbal drug material for potential use against liver diseases, at molecular level for the efficacy linked to ethnobotanical documented data.Different herbal extracts were prepared and standardized by HPLC, according to European Pharmacopoeia. Initially 0.25 mg/mL each standardized extract was applied to oleic+palmitic acid induced fatty liver using a HepG2 cell culture model. ALT, AST, GSH, and MDA levels were comparatively analyzed, in addition to cell Nil Red staining. The highest activity for MDA reduction was observed for the A. sativum extract at 48.2% level, followed by 36.4% for M. sylvestris , and S. fruticosa extracts with 27.3% reduction, respectively. Glutathione levels increased to 59.1% when A. sativum extract was applied. M. sylvestris extract increased the glutathione levels in the medium by 49.7%; S. fruticosa extract decreased ALT levels by 53.5% and M. sylvestris extract by 38.5%, whereas the standard resveratrol reduced ALT level by 30.9%, respectively. The AST levels for M. sylvestris extract was 46.5%, compared to resveratrol by 93%. A. sativum, M. sylvestris, and S. fruticosa standard extracts showed relatively good correlation and activity where further in vivo studies should be performed.","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Research in Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29228/jrp.467","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

: Salvia fruticosa leaves, Malva sylvestris flowers, Taraxacum officinale aerial parts, Plantago ovata seeds, Tanacetum parthenium aerial parts, and Allium sativum bulbs are documented for traditional use against hepatic disorders and different liver diseases. To evaluate herbal drug material for potential use against liver diseases, at molecular level for the efficacy linked to ethnobotanical documented data.Different herbal extracts were prepared and standardized by HPLC, according to European Pharmacopoeia. Initially 0.25 mg/mL each standardized extract was applied to oleic+palmitic acid induced fatty liver using a HepG2 cell culture model. ALT, AST, GSH, and MDA levels were comparatively analyzed, in addition to cell Nil Red staining. The highest activity for MDA reduction was observed for the A. sativum extract at 48.2% level, followed by 36.4% for M. sylvestris , and S. fruticosa extracts with 27.3% reduction, respectively. Glutathione levels increased to 59.1% when A. sativum extract was applied. M. sylvestris extract increased the glutathione levels in the medium by 49.7%; S. fruticosa extract decreased ALT levels by 53.5% and M. sylvestris extract by 38.5%, whereas the standard resveratrol reduced ALT level by 30.9%, respectively. The AST levels for M. sylvestris extract was 46.5%, compared to resveratrol by 93%. A. sativum, M. sylvestris, and S. fruticosa standard extracts showed relatively good correlation and activity where further in vivo studies should be performed.
抗肝脏疾病的传统草药- HepG2细胞诱导脂肪变性的体外实验
:鼠尾草叶、锦葵花、蒲公英空中部分、车前草种子、天竺葵空中部分和葱球茎被记录为治疗肝脏疾病和不同肝脏疾病的传统用途。以民族植物学文献资料为依据,在分子水平上评估草药治疗肝脏疾病的潜在用途。根据欧洲药典,采用高效液相色谱法制备不同的草药提取物并进行标准化。采用HepG2细胞培养模型,将每种标准提取物0.25 mg/mL分别应用于油酸+棕榈酸诱导的脂肪肝。对比分析ALT、AST、GSH、MDA水平,并对细胞进行Nil Red染色。对MDA的还原活性最高的是芥花提取物,其还原活性为48.2%,其次是牛蒡提取物,其还原活性为36.4%,而牛蒡提取物的还原活性为27.3%。应用苜蓿提取物时,谷胱甘肽含量增加到59.1%。黄芪提取物使培养基中的谷胱甘肽水平提高了49.7%;枸杞提取物降低ALT水平53.5%,山羊草提取物降低ALT水平38.5%,而标准白藜芦醇分别降低ALT水平30.9%。与白藜芦醇相比,西林草提取物的AST含量为46.5%,高出93%。sativum, M. sylvestris和S. fruticosa标准提取物显示出相对较好的相关性和活性,需要进一步进行体内研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Research in Pharmacy
Journal of Research in Pharmacy PHARMACOLOGY & PHARMACY-
CiteScore
1.00
自引率
12.50%
发文量
80
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信